LEMONAID takes on the challenge of developing a new drug against Diffuse Large B-Cell Lymphoma (DLBC...
[EDIT]: This event is now hold digitally, and we are looking forward to talking to you at one of our...
As of April 2020, Wim Tiest has joined InnoSer in the role of Chief Technology Officer (CTO) and as ...
Despite the challenging times for the life sciences sector during coronavirus restrictions, we’ve be...
Press release | Leiden, 19 March 2020
Following the most recent governmental advice and regulations, we have decided to take preventative ...
InnoSer is joining forces with OrganoTherapeutics to make midbrain organoids available for screening...
InnoSer and TheraIndx announce their strategic partnership to better serve pharmaceutical and biomed...
InnoSer is expanding its infrastructure to better its in vitro services. These specialized services ...
53 million people were affected by Alzheimer’s Disease (AD) in 2013. This was a steep rise from 26.6...